Clinical Trials Logo

Clinical Trial Summary

A prospective, single-arm, multi-center, non-randomized, pre-market study designed to provide clinical data regarding the use of the AcQMap High Resolution Imaging and Mapping System during an atrial fibrillation retreatment ablation procedure.


Clinical Trial Description

A prospective, single-arm, multi-center, non-randomized, pre-market study designed to provide clinical data regarding the use of the AcQMap High Resolution Imaging and Mapping System during an atrial fibrillation retreatment ablation procedure. The patient population inlcudes men and women, eighteen (10) years of age or older, who in the past twenty-four (24) months have had no more than two (2) previous left-atrial ablations for AF treatment. The treatment plan must include evaluation and ablation (as indicated) of pulmonary vein reconnections plus AcQMap guided non-PV substrate ablation. Subject assessments will occr at screening, procedure, hospital discharge, 3-, 6-, and 12-months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03467126
Study type Interventional
Source Acutus Medical
Contact Steven McQuillan, BS
Phone 442.232.6080
Email steven.mcquillan@acutusmedical.com
Status Not yet recruiting
Phase N/A
Start date January 2019
Completion date May 2020

See also
  Status Clinical Trial Phase
Completed NCT02459574 - Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation N/A
Completed NCT03368781 - AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation N/A
Recruiting NCT05776797 - AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation N/A